Nevertheless, the secondary cohort was used for validation, and combined analysis of both cohorts produced more robust results for SNVs in genes, such as LRRK2. Moreover, use of the large KGP dataset as a healthy control group facilitated the additional identification of known PD genes, such as SNCA and PRKN (Parkin). Here, PRKN is linked to Parkinson disease.